COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,555 Articles (22,400 medRxiv, 8,155 bioRxiv)

Most recent first Previous |  Page 2005: Articles 20041-20050  | Next

Combined in silico docking and in vitro antiviral testing for drug repurposing identified lurasidone and elbasvir as SARS-CoV-2 and HCoV-OC43 inhibitors
Milani, M., Donalisio, M., Bonotto, R. M., Schneider, E., Arduino, I., Boni, F., Lembo, D., Marcello, A., Mastrangelo, E.
10.1101/2020.11.12.379958 — Posted: 2020-11-12
Molecular Mimicry Map (3M) of SARS-CoV-2: Prediction of potentially immunopathogenic SARS-CoV-2 epitopes via a novel immunoinformatic approach
An, H., Park, J.
10.1101/2020.11.12.344424 — Posted: 2020-11-12
The repurposed drugs suramin and quinacrine inhibit cooperatively in vitro SARS-CoV-2 3CLpro
Eberle, R. J., Olivier, D. S., Amaral, M. S., Willbold, D., Arni, R. K., Coronado, M. A.
10.1101/2020.11.11.378018 — Posted: 2020-11-12
Can we predict the severe course of COVID-19? A systematic review and meta-analysis of indicators of clinical outcome.
Katzenschlager, S., Zimmer, A. J., Gottschalk, C., Grafeneder, J., Seitel, A., Maier-Hein, L., Benedetti, A., Larmann, J., Weigand, M. A., McGrath, S., Denkinger, C.
10.1101/2020.11.09.20228858 — Posted: 2020-11-12
Changes in sexual behavior, PrEP adherence, and access to sexual health services due to the COVID-19 pandemic among a cohort of PrEP-using MSM in the South
Pampati, S., Emrick, K., Siegler, A. J., Jones, J.
10.1101/2020.11.09.20228494 — Posted: 2020-11-12
The Individual and Social Determinants of COVID-19 in Ontario, Canada: A Population-Wide Study
Sundaram, M., Calzavara, A., Mishra, S., Kustra, R., Chan, A., Hamilton, M. A., Djebli, M., Rosella, L. A., Watson, T., Chen, H., Chen, B., Baral, S., Kwong, J.
10.1101/2020.11.09.20223792 — Posted: 2020-11-12
Impact of public and private sector COVID-19 diagnostics and treatments on US healthcare resource utilization
Sheinson, D., Wong, W., Solon, C., Cheng, M., Elsea, D., Meng, Y., Shah, A.
10.1101/2020.11.09.20228452 — Posted: 2020-11-12
Validation and testing of a method for detection of SARS-CoV-2 RNA in healthy human stool
Coryell, M., Iakiviak, M., Pereira, N., Murugkar, P. P., Rippe, J., Williams, D., Hastie, J., Sava, R., Lien, C., Wang, T., Muller, W. J., Fischbach, M., Carlson, P.
10.1101/2020.11.09.20228601 — Posted: 2020-11-12
Peginterferon-lambda for the treatment of COVID-19 in outpatients
Feld, J. J., Kandel, C., Biondi, M. J., Kozak, R. A., Zahoor, M. A., Lemieux, C., Borgia, S. M., Boggild, A. K., Powis, J., McCready, J., Tan, D. H., Chan, T., Coburn, B., Kumar, D., Humar, A., Chan, A., O'Neil, B., Noureldin, S., Booth, J., Hong, R., Smookler, D., Aleyadeh, W., Patel, A., Barber, B., Casey, J., Hiebert, R., Mistry, H., Choong, I., Hislop, C., Santer, D., Tyrrell, D. L., Glenn, J. S., Gehring, A. J., Janssen, H. L., Hansen, B.
10.1101/2020.11.09.20228098 — Posted: 2020-11-12
Retrospective Analyses of Interventions to Epidemics using a Continuously Updated Model, with Application to the COVID-19 Crisis in New York City
Osborn, J., Berman, S., Bender_Bier, S., D'Souza, G., Myers, M.
10.1101/2020.11.09.20228684 — Posted: 2020-11-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).